Shenzhen-based Haisco Pharmaceutical Group Co., Ltd (SHE: 002653) has announced the registration of a new business in Delaware, United States. The company has established a USD 50,000 subsidiary named Hexgen Pharmaceutical Holding Limited, marking its latest move to accelerate global expansion and enhance its core competitiveness on an international scale.
The establishment of Hexgen Pharmaceutical Holding Limited reflects Haisco’s strategic ambition to strengthen its presence in the global pharmaceutical market. By setting up operations in Delaware—a state renowned for its favorable corporate laws and business-friendly environment—the company aims to streamline its international activities, better serve global markets, and access new opportunities for growth.
This move underscores Haisco’s commitment to diversifying its operations and building a stronger foothold in the global pharma industry. Hexgen Pharmaceutical Holding Limited will play a pivotal role in helping the company achieve its long-term goals of expanding its global footprint and increasing its competitiveness in an increasingly interconnected market.-Fineline Info & Tech
